ExpreS2ion announces exercise of 2017 warrant program
Hørsholm, Denmark, August 3, 2020 – ExpreS2ion Biotech Holding AB (“ExpreS2ion” or “the Company”) today announces that all warrants held by employees and Board members under the 2017 Warrant Program, established in April 2017, have been fully exercised. In total, 436,200 warrants were exercised, providing ExpreS2ion SEK 2,656,632. The exercise has increased the number of shares by 436,200, from 15,929,691 to 16,365,891.At an Extra General Meeting in ExpreS[2]ion held on April 19, 2017, it was resolved to issue warrants as part of an incentive program for employees and Board members, “the